Abstract

REVIEW ON ARJUNA (TERMINALIA ARJUNA ROXB.) WITH SPECIAL REFERENCE TO PRAMEHA (DIABETES)

Satpudke Shweta Shaligram*, Pansare Tabassum Arif and Khandekar Surekha Babasaheb

Abstract

Prameha (Diabetes) has become a global problem and also well described in the ancient Indian classics like Vedas. As of 2016, an estimated 387 million people have diabetes worldwide. Arjuna (Terminalia Arjuna Roxb.) is an important medicinal plant used in ayurvedic formulations. Ayurvedic classics texts have mentioned Arjuna in treatment of Prameha due to its predominance of Kashaya rasa, Katu vipaka and Laghu, Ruksha guna and Kaphashoshan (absorption of Kapha) and Shothagna (anti-inflammatory) actions. Properties of Arjuna like Pramehaghna (Anti-diabetic), Hridya (Cardio protective), Medoghna (Anti-obesity) and Vrana ropan (wound healing) are well described in Ayurveda which help to treat comorbidities of Prameha. The major chemical constituents of Terminalia arjuna are Flavonoids, Tannins, Saponins, Alkaloids, Glycosides which explains anti-diabetic activity. Arjuna have diverse medicinal properties like Anti-oxidant, Anti- hyperlipidemic, Antidiabetic, Anti-obesity, Wound healing property, Analgesic activity, Antifungal activity, Antiinflammation activities useful against Diabetes. Arjuna is also screened for effective in diabetic complications like Nephropathy, Cardiovascular autonomic neuropathy. This review gives detail information regarding importance and role of Arjuna in treatment of Prameha according to Ayurvedic and modern pharmacological aspect.

Keywords: Aruna, Terminalia Arjuna, Prameha, Diabetes.